by Queen Mary, University of London Heart MRI scan showing the area of fat detected by the AI tool. Credit: Queen Mary, University of London A team led by researchers from the Queen Mary University of London has developed a new artificial intelligence (AI) tool that is able to automatically measure the amount of fat around...
Category: <span>Diabetes</span>
Demand is growing for continuous glucose monitoring for type 2 diabetes. Primary care doctors need to prepare
By Katie Palmer June 30, 2021 ADOBE In the last year, Jai Smith has cycled through 13 primary care doctors. Ever since being diagnosed with type 2 diabetes in 1995, she’s tried her best to manage a disease that has devastated her family: Her grandmother and four uncles died from its complications. But she’s struggled to...
Study finds time-restricted eating may reduce diabetes-related hypertension
by Elizabeth Chapin, University of Kentucky Credit: CC0 Public Domain A new University of Kentucky College of Medicine study suggests that time-restricted eating may be able to help people with Type 2 diabetes reduce nocturnal hypertension, which is characterized by elevated blood pressure at night. The study published in PNAS on June 22 found that time-restricted...
A promising new pathway to treating type 2 diabetes
by Rosemary Brandt, University of Arizona Benjamin Renquist, an associate professor in the UArizona School of Animal and Comparative Biomedical Research. Credit: University of Arizona This year marks the 100th anniversary of the discovery of insulin, a scientific breakthrough that transformed Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, from a terminal disease...
‘Stunning’ Twincretin Beats Semaglutide in Type 2 Diabetes
Mitchel L. Zoler, PhD June 27, 2021 Tirzepatide, a novel “twincretin” agent, was superior to 1-mg semaglutide treatments for reducing both hemoglobin A1c levels and body weight in patients with type 2 diabetes in a pivotal, 40-week, head-to-head trial with nearly 1,900 randomized patients, one of four positive pivotal trial results reported for tirzepatide at the annual...
New report explains microbiome impact on glucose control
THE GINGER NETWORK IMAGE: Pendulum Glucose Control, the first-of-its-kind formulation of both probiotics and a prebiotic, is changing dietary management of type 2 diabetes. In a double-blind, randomized placebo-controlled study, Pendulum Glucose Control reduced A1c levels by 0.6% compared to placebo and generated a 33% reduction in postprandial glucose spikes (Area Under the Curve or...
Systolic blood pressure above 120 mmHg increases rate of cardiovascular disease
by Niigata University Rates of CAD and CVD. Credit: Niigata University An estimated 1.13 billion people worldwide have hypertension or high blood pressure, and two-thirds of these individuals are living in low- and middle-income countries. Blood pressure is the force manifested by circulating blood against the walls of the body’s arteries, the major blood vessels...
Further hope for BCG vaccine in stemming type 1 diabetes
by Massachusetts General Hospital Credit: Pixabay/CC0 Public Domain At the recent 2021 Annual Scientific Sessions of the American Diabetes Association, researchers from Massachusetts General Hospital (MGH) presented positive updates on their trials of the bacillus Calmette-Guérin (BCG) vaccine to safely and significantly lower blood sugars. In type 1 diabetes, an autoimmune disease that currently has no cure, T...
Rap1 controls the body’s sugar levels from the brain
by Baylor College of Medicine Modifying the activity of gene Rap1 in VMH neurons of the hypothalamus can regulate blood glucose in an animal model. Credit: M. Fukuda/JCI insight, 2021 Managing type 2 diabetes typically involves losing weight, exercise, and medication, but new research by Dr. Makoto Fukuda and colleagues at Baylor College of Medicine and...
Study shows high rates of kidney disease among adults with diabetes
by National University of Ireland, Galway Dr. Tomás Griffin, consultant endocrinologist specializing in diabetes care at Galway University Hospitals, Honorary Senior Lecturer at NUI Galway and lead researcher on the study, along with Clinical Trial Nurse Michelle Hennessy with patient Brian Curran at UHG. Credit Aengus McMahon. Credit: Aengus McMahon Some 42% of patients attending a...